The Safety and Efficacy of Intravenous EXG110 in Patients With Fabry Disease

NCT06819514 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
16
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Guangzhou Jiayin Biotech Ltd